Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:02048203n
Noun Concept
Categories: Abandoned drugs, Tyrosine kinase inhibitors, Oxazoles, Drugs not assigned an ATC code, Trifluoromethyl compounds
EN
mubritinib  TAK-165  TAK165  TAK 165
EN
Mubritinib is a protein kinase inhibitor which was under development by Takeda for the treatment of cancer. Wikipedia
Definitions
Relations
Sources
EN
Mubritinib is a protein kinase inhibitor which was under development by Takeda for the treatment of cancer. Wikipedia
IS A
compound
enzyme inhibitor
PHYSICALLY INTERACTS WITH
Erb-b2 receptor tyrosine kinase 2
Wikipedia
EN
mubritinib
Wikidata
EN
mubritinib
Wikidata Alias
EN
Mubritinib, TAK-165, TAK165, TAK 165

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License